Lauren Shapiro

7PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2025
Adding the FcRn antagonist efgartigimod for the prevention of IgG-mediated complications in the peri-transplant period.

Dennis L Cooper, Jhannine Alyssa Verceles, Taba Kheradmand

|Feb 07, 2025
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study.

Ioannis Mantzaris, Mendel Goldfinger, Matan Uriel

|Sep 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.

Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri

|Jun 21, 2023
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.

David Levitz, Yogen Saunthararajah, Kateryna Fedorov

Pageof 2

Frequent Collaborators

4 joint publications

Mendel Goldfinger

4 joint publications

Marina Konopleva

3 joint publications

Dennis L Cooper

3 joint publications

Kira Gritsman